Ranbaxy Admits To Infringing Purdue OxyContin Patent
Ranbaxy Pharmaceuticals Inc. has admitted to infringing a Purdue Pharma LP patent for the painkiller OxyContin in a consent order resolving Purdue's suit, which had been tied to antitrust multidistrict litigation...To view the full article, register now.
Already a subscriber? Click here to view full article